Table 1.
Demographic data of survivors vs. non-survivors (*t-test, χ2 chi sq, UMann Whitney U-test).
| Survivors | Non-survivors | P-value | |
|---|---|---|---|
| n | 53 (85.4%) | 9 (14.6%) | |
| Age yrs. mean (SD) | 6.87 (5.49) | 9.0 (5.04) | 0.27* |
| Gender M:F | 31:22 (58% male) | 3:6 (33% male) | 0.1χ2 |
| Hospital vs. community acquired infection | 33:20 (62% hospital acquired) | 5:4 (55% hospital acquired) | 0.7χ2 |
| Co-morbidities | None 29, liver transplant 6, cerebral palsy 4, other syndromic 4, liver disease 3, leukemia 3, bone marrow transplant 2, sickle cell disease 1, urea cycle disorder 1 | None 3, liver transplant 1, leukemia 1, sickle cell disease 1, urea cycle disorder 1, cystic fibrosis 1, muscular dystrophy 1 | |
| On Immunosuppression (steroids or tacrolimus) | 17 (32%) | 4 (44%) | 0.47χ2 |
| Ventilated on admission | 51 (96%) | 9 (100%) | 0.5χ2 |
| CVVH (n) | 6 (11%) | 3 (33%) | 0.08χ2 |
| PIM2 score mean(SD) | 31.33 (29.08) | 54.47 (32.11) | 0.03* |
| PICU stay median (range) days | 6 (2–122) | 2 (0–20) | 0.002U |